Sofosbuvir faces fresh patent challenge in Europe.
作者信息
Stafford Ned
机构信息
Hamburg.
出版信息
BMJ. 2017 Mar 30;356:j1632. doi: 10.1136/bmj.j1632.
PMID:28360141
Abstract
摘要
相似文献
1
Sofosbuvir faces fresh patent challenge in Europe.
BMJ. 2017 Mar 30;356:j1632. doi: 10.1136/bmj.j1632.
2
Questions hang over European patent for hepatitis C drug after ruling.
BMJ. 2016 Oct 10;355:i5493. doi: 10.1136/bmj.i5493.
3
Indian hepatitis C drug patent decision shakes public health community.印度丙肝药物专利裁决震动公共卫生界。
Lancet. 2016 Jun 4;387(10035):2272-2273. doi: 10.1016/S0140-6736(16)30656-0. Epub 2016 May 26.
4
Brazil's Fight against Hepatitis C - Universalism, Local Production, and Patents.巴西对抗丙型肝炎——普遍主义、本地生产与专利
N Engl J Med. 2019 Feb 14;380(7):605-607. doi: 10.1056/NEJMp1812959.
5
Patent battle lines drawn as sofosbuvir gains approval.随着索非布韦获批，专利战线已然划定。
Nat Rev Drug Discov. 2014 Jan;13(1):12. doi: 10.1038/nrd4220.
6
Sofosbuvir for treatment of chronic hepatitis C.索磷布韦用于治疗慢性丙型肝炎。
Hepatol Int. 2015 Apr;9(2):161-73. doi: 10.1007/s12072-014-9606-9. Epub 2015 Jan 28.
7
Idenix files three patent infringement lawsuits in Europe.艾迪尼克斯公司在欧洲提起三起专利侵权诉讼。
Pharm Pat Anal. 2014 May;3(3):225.
8
The evolution of the therapeutic strategy in hepatitis C: features of sofosbuvir and indications.丙型肝炎治疗策略的演变：索磷布韦的特点及适应证
Dig Liver Dis. 2014 Dec 15;46 Suppl 5:S174-8. doi: 10.1016/j.dld.2014.09.028. Epub 2014 Nov 11.
9
Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C.在使用索磷布韦、西米普明和利巴韦林治疗1b型丙型肝炎的新型直接抗病毒药物（DAA）治疗期间出现的结肠炎。
Infection. 2016 Dec;44(6):811-812. doi: 10.1007/s15010-016-0915-x. Epub 2016 Jun 16.
10
Ledipasvir and sofosbuvir for recurrent hepatitis C after liver transplantation.来迪派韦索磷布韦片治疗肝移植后复发的丙型肝炎。
Biosci Trends. 2017 Jan 16;10(6):496-499. doi: 10.5582/bst.2016.01223. Epub 2016 Dec 18.
引用本文的文献
1
Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.在中低收入国家和地区，治疗倡导者采取策略扩大艾滋病毒和丙型肝炎病毒抗病毒治疗的可及性：确保不落下任何人。
J Int AIDS Soc. 2018 Apr;21 Suppl 2(Suppl Suppl 2):e25060. doi: 10.1002/jia2.25060.
Zotero 插件